Drugmakers including Pfizer, Sanofi, and Takeda Pharmaceutical plan to raise prices on more than 500 unique drugs in early January, according to data analyzed by 3 Axis Advisors.
New medications provide hope to patients looking for sustainable weight loss, but they also raise questions related to high costs, insurance coverage and long-term effectiveness.
Manufacturer GSK has said it's discontinuing the branded asthma inhaler Flovent, and instead is making an 'authorized generic' version, which is identical but without the same branding.